BDSX - BIODESIX INC

18.78
2.920   15.548%

Share volume: 384,536
Last Updated: 03-06-2026
Healthcare/Services – Health: -0.05%

PREVIOUS CLOSE
CHG
CHG%
$15.86
2.92
0.18%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
43%
Profitability 43%
Dept financing 40%
Liquidity 24%
Performance 50%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
19.24%
1 Month
89.12%
3 Months
141.08%
6 Months
4,245.21%
1 Year
2,078.15%
2 Year
1,152.00%
Key data
Stock price
$18.78
P/E Ratio 
0.00
DAY RANGE
$15.24 - $18.99
EPS 
-$1.81
52 WEEK RANGE
$0.17 - $18.99
52 WEEK CHANGE
$2,229.16
MARKET CAP 
54.099 M
YIELD 
N/A
SHARES OUTSTANDING 
9.858 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-07-2025
BETA 
0.88
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$213,456
AVERAGE 30 VOLUME 
$155,029
Company detail
CEO: Scott Hutton
Region: US
Website: biodesix.com
Employees: 220
IPO year: 2020
Issue type: Common Stock
Market: XNAS
Industry: Healthcare/Services – Health
Sector: Services

Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests to assess the risk of lung cancer and help in identifying the appropriate treatment pathway and help physicians in reclassifying risk of malignancy in patients with suspicious lung nodules.

Recent news